NASDAQ:VERO 16 December 2025 - 20 January 2026

Shares of Venus Concept Inc. dropped roughly 43% on Tuesday, erasing much of last week’s sharp gains and keeping the microcap under traders’ watch. The Nasdaq-listed medical aesthetics firm slid $3.46 to $4.54 by late morning, after bouncing between $3.85 and $5.06.

Venus Concept Inc shares ended Friday at $8.00, surging 459.44% from the previous session. The stock fluctuated between $5.68 and $12.93 during the day. Trading volume hit roughly 307.6 million shares, a notable jump from recent levels for the Nasdaq-listed microcap.

Shares of Venus Concept Inc exploded 451.9%, closing Friday at $7.89 and hovering near $8.00 in after-hours. The stock had ended Thursday at $1.43 but spiked to an intraday peak of $12.70 after Madryn Asset Management’s amended Schedule 13D revealed it owns roughly 91% of the company. The filing also flagged a possible “delisting and deregistration” tied to cost-cutting moves. Trading volume was heavy, with about 307 million shares swapping hands. Still, the price also slid to a low of $2.27 within the session.

Venus Concept Inc. shares surged over 390% on Friday, closing near $7.06 after an early range from $2.27 to $7.75. Trading volume exceeded 155 million shares.

Venus Concept Inc. stock is back on traders’ radar in mid-December 2025—less because it’s a calm, steadily compounding story, and more because the company has stacked multiple high-impact catalysts and balance-sheet developments into a tight window.